Johnson & Johnson $3.4 billion acquisition of Auris Health

13/2/2019

Public acquisition

Value:

$ 3.4 billion

Status:

Announced

Date:

13/2/2019

Overview:

Johnson & Johnson has made a $3.4 billion acquisition of Auris Health.
Auris is a robotics surgery company.
The transaction is expected to close by the end of the second quarter of 2019.

Kurt Stumpo - US Editor

Jurisdiction:

United States

Deal type:

Public acquisition

Practice area:

M&A

Governing law:

United States

Industry sectors:

Healthcare
Pharmaceuticals and life sciences
Technology and telecommunications

Firms:

Cravath Swaine & Moore

Party: Johnson & Johnson (Acquirer)

Lawyer: Robert Townsend III

Wachtell Lipton Rosen & Katz

Party: Auris Health (Target)

Lawyers: Gregory Pessin, Mark Gordon, Ronald Chen

Related deals